MCDERMOTT+ LLC for CLINICAL LABORATORY FEE SCHEDULE REFORM COALITION
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare reimbursement for laboratory tests.
Foreign entity interest: The foreign entities identified on Form LD-1 have ownership interests in the subsidiaries that participate in this Coalition, and would be affected financially by changes to Medicare payment for certain laboratory tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL RADENSKY | — |
| ERIC ZIMMERMAN | — |
Health Issues HCR
Issues concerning regulation of laboratory tests.
Foreign entity interest: The foreign entities identified on Form LD-1 have ownership interests in the subsidiaries that participate in this Coalition, and would be affected financially by changes to Medicare payment for certain laboratory tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL RADENSKY | — |
| ERIC ZIMMERMAN | — |
Medical/Disease Research/Clinical Labs MED
Issues concerning regulation of laboratory tests.
Foreign entity interest: The foreign entities identified on Form LD-1 have ownership interests in the subsidiaries that participate in this Coalition, and would be affected financially by changes to Medicare payment for certain laboratory tests.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL RADENSKY | — |
| ERIC ZIMMERMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.